Aerosol Formation During Processing of Potentially Infectious Samples on Roche Immunochemistry Analyzers (cobas e analyzers) and in an End-to-End Laboratory Workflow to Model SARS-CoV-2 Infection Risk for Laboratory Operators
Géza V. Burghardt, Markus Eckl, Doris Huether, Oliver H. D. Larbolette, Alessia Lo Faso, Beatus Ofenloch-Haehnle, Marlene A. Riesch, Rolf A. Herb
This study assesses aerosol formation during infectious sample processing on Roche analyzers and in a lab workflow, using HBsAg as a surrogate for SARS-CoV-2, finding low aerosol production with remote infection risk.
Frontiers in Public Health · Nov 16, 2022Peer-reviewedMolecular Biology